Fundraising Fox

Gregg L. Semenza

Investor

Venture Partner at Catalio Capital Management, LP

Baltimore, Maryland

Writes $100K – $5M checks Β· typically $1.5M

About

Gregg L. Semenza is the C. Michael Armstrong Professor of Genetic Medicine at Johns Hopkins School of Medicine and directs the Armstrong Oxygen Biology Research Center at Johns Hopkins Medicine. His research spans angiogenesis, cancer biology, oxygen biology, and transcriptional regulation. He earned a BA from Harvard College, an MD/PhD from the University of Pennsylvania, completed residency at Duke University Medical Center and a fellowship at Johns Hopkins, and received the 2019 Nobel Prize in Physiology or Medicine.

Invests in

Biotech

Experience

  1. Johns Hopkins University School of MedicineC. Michael Armstrong Professor of Genetic Medicinecurrent1990 β€” presentBaltimore, Maryland USA

Investments

Investor

HIF Therapeutics, Inc.

Per the firm's website.

Colleagues at Catalio Capital Management, LP

Frequently asked questions

Who is Gregg L. Semenza?
Gregg L. Semenza is the C. Michael Armstrong Professor of Genetic Medicine at Johns Hopkins School of Medicine and directs the Armstrong Oxygen Biology Research Center at Johns Hopkins Medicine. His research spans angiogenesis, cancer biology, oxygen biology, and transcriptional regulation. He earned a BA from Harvard College, an MD/PhD from the University of Pennsylvania, completed residency at Duke University Medical Center and a fellowship at Johns Hopkins, and received the 2019 Nobel Prize in Physiology or Medicine.
Where does Gregg L. Semenza work?
Gregg L. Semenza is Venture Partner at Catalio Capital Management, LP.
What does Gregg L. Semenza invest in?
Gregg L. Semenza invests in Biotech.
What check size does Gregg L. Semenza write?
Gregg L. Semenza typically writes checks of $100K – $5M.
What companies has Gregg L. Semenza invested in?
Investments tracked here include HIF Therapeutics, Inc..